• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Urokinase Product Approval Information - New Drug Application 10/10/02

Product name: Urokinase (Abbokinase)
Manufacturer: Abbott Laboratories, Abbott Park, IL
Intended Use: for adults for the lysis of acute massive pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments, and for the lysis of pulmonary emboli accompanied by unstable hemodynamics, i.e., failure to maintain blood pressure without supportive measures
Approval Date: 10/10/2002
Type of submission: New Drug application supplement


Approval Letter - (PDF)

Label - (PDF) 


Other Information on Urokinase